A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...
The global cerebrospinal fluid management devices market size was valued at USD 1.21 billion in 2024 and is projected to grow from USD 1.27 billion in 2025 to reach USD 1.74 billion by 2033 , ...